OBJECTIVE: The prevalence of peripheral artery disease (PAD) increases with aging and is higher in persons with metabolic syndrome and diabetes. PAD is associated with adverse outcomes, including frailty and disability. The protective effect of testosterone and sex hormone binding globulin (SHBG) for diabetes in men suggests that the biological activity of sex hormones may affect PAD, especially in older populations. METHODS: Nine hundred and twenty-one elderly subjects with data on SHBG, testosterone (T), estradiol (E2) were selected from InCHIANTI study. PAD was defined as an Ankle-Brachial Index (ABI) < 0.90. Logistic regression models adjusted for age (Model 1), age, BMI, insulin, interleukin-6, physical activity, smoking, chronic diseases including metabolic syndrome (Model 2), and a final model including also sex hormones (Model 3) were performed to test the relationship between SHBG, sex hormones and PAD. RESULTS: The mean age (±SD) of the 419 men and 502 women was 75.0 ± 6.8 years. Sixty two participants (41 men, 21 women) had ABI < 0.90. Men with PAD had SHBG levels lower than men without PAD (p = 0.03). SHBG was negatively and independently associated with PAD in men (p = 0.028) but not in women. The relationship was however attenuated after adjusting for sex hormones (p = 0.07). The E2 was not significantly associated with PAD in both men and women. In women, but not in men, T was positively associated with PAD, even after adjusting for multiple confounders, including E2 (p = 0.01). CONCLUSIONS: Low SHBG and high T levels are significantly and independently associated with the presence of PAD in older men and women, respectively.
OBJECTIVE: The prevalence of peripheral artery disease (PAD) increases with aging and is higher in persons with metabolic syndrome and diabetes. PAD is associated with adverse outcomes, including frailty and disability. The protective effect of testosterone and sex hormone binding globulin (SHBG) for diabetes in men suggests that the biological activity of sex hormones may affect PAD, especially in older populations. METHODS: Nine hundred and twenty-one elderly subjects with data on SHBG, testosterone (T), estradiol (E2) were selected from InCHIANTI study. PAD was defined as an Ankle-Brachial Index (ABI) < 0.90. Logistic regression models adjusted for age (Model 1), age, BMI, insulin, interleukin-6, physical activity, smoking, chronic diseases including metabolic syndrome (Model 2), and a final model including also sex hormones (Model 3) were performed to test the relationship between SHBG, sex hormones and PAD. RESULTS: The mean age (±SD) of the 419 men and 502 women was 75.0 ± 6.8 years. Sixty two participants (41 men, 21 women) had ABI < 0.90. Men with PAD had SHBG levels lower than men without PAD (p = 0.03). SHBG was negatively and independently associated with PAD in men (p = 0.028) but not in women. The relationship was however attenuated after adjusting for sex hormones (p = 0.07). The E2 was not significantly associated with PAD in both men and women. In women, but not in men, T was positively associated with PAD, even after adjusting for multiple confounders, including E2 (p = 0.01). CONCLUSIONS: Low SHBG and high T levels are significantly and independently associated with the presence of PAD in older men and women, respectively.
Authors: Marcello Maggio; Gian Paolo Ceda; Fulvio Lauretani; Stefania Bandinelli; E Jeffrey Metter; Andrea Artoni; Elisa Gatti; Carmelinda Ruggiero; Jack M Guralnik; Giorgio Valenti; Shari M Ling; Shehzad Basaria; Luigi Ferrucci Journal: J Clin Endocrinol Metab Date: 2008-12-02 Impact factor: 5.958
Authors: Marcello Maggio; Fulvio Lauretani; Gian Paolo Ceda; Stefania Bandinelli; Shehzad Basaria; Alessandro Ble; Josephine Egan; Giuseppe Paolisso; Samer Najjar; E Jeffrey Metter; Giorgio Valenti; Jack M Guralnik; Luigi Ferrucci Journal: J Am Geriatr Soc Date: 2006-12 Impact factor: 5.562
Authors: Marcello Maggio; Fulvio Lauretani; Gian Paolo Ceda; Stefania Bandinelli; Shehzad Basaria; Giuseppe Paolisso; Alessandro Ble; Josephine M Egan; E Jeffrey Metter; Angela M Abbatecola; Giovanni Zuliani; Carmelinda Ruggiero; Giorgio Valenti; Jack M Guralnik; Luigi Ferrucci Journal: Am J Physiol Endocrinol Metab Date: 2006-09-12 Impact factor: 4.310
Authors: Sarinnapha Vasunilashorn; Antonia K Coppin; Kushang V Patel; Fulvio Lauretani; Luigi Ferrucci; Stefania Bandinelli; Jack M Guralnik Journal: J Gerontol A Biol Sci Med Sci Date: 2009-01-31 Impact factor: 6.053
Authors: Annabelle Rodriguez; Denis C Muller; E Jeffrey Metter; Marcello Maggio; S Mitchell Harman; Marc R Blackman; Reubin Andres Journal: J Clin Endocrinol Metab Date: 2007-06-26 Impact factor: 5.958
Authors: Mary M McDermott; Lu Tian; Kiang Liu; Jack M Guralnik; Luigi Ferrucci; Jin Tan; William H Pearce; Joseph R Schneider; Michael H Criqui Journal: J Am Coll Cardiol Date: 2008-04-15 Impact factor: 24.094
Authors: L Antonio; D Vanderschueren; N Narinx; K David; J Walravens; P Vermeersch; F Claessens; T Fiers; B Lapauw Journal: Cell Mol Life Sci Date: 2022-10-07 Impact factor: 9.207
Authors: João Henrique Fonseca do Nascimento; André Gusmão Cunha; André Bouzas de Andrade; Monique Magnavita Borba da Fonseca Cerqueira Journal: J Vasc Bras Date: 2022-01-07